Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mohl BP"'
Autor:
Mohl BP; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald-Insel Riems, Germany., Blaurock C; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald-Insel Riems, Germany., Breithaupt A; Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald-Insel Riems, Germany., Riek A; Institute of Animal Welfare and Animal Husbandry, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Doernbergstraße 25, 29223 Celle, Germany., Speakman JR; School of Biological Sciences, University of Aberdeen, Aberdeen AB24 2TZ, UK., Hambly C; School of Biological Sciences, University of Aberdeen, Aberdeen AB24 2TZ, UK., Bokelmann M; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald-Insel Riems, Germany.; Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany., Pei G; Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald-Insel Riems, Germany., Sadeghi B; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald-Insel Riems, Germany., Dorhoi A; Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald-Insel Riems, Germany., Balkema-Buschmann A; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald-Insel Riems, Germany.
Publikováno v:
Viruses [Viruses] 2024 Oct 31; Vol. 16 (11). Date of Electronic Publication: 2024 Oct 31.
Autor:
Mohl BP; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany., Blaurock C; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany., Riek A; Institute of Animal Welfare and Animal Husbandry, Friedrich-Loeffler-Institut, Celle, Germany., Hambly C; School of Biological Sciences, University of Aberdeen, Aberdeen, UK., Speakman JR; School of Biological Sciences, University of Aberdeen, Aberdeen, UK., Balkema-Buschmann A; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany. Anne.Balkema-Buschmann@fli.de.
Publikováno v:
Scientific reports [Sci Rep] 2024 Oct 06; Vol. 14 (1), pp. 23263. Date of Electronic Publication: 2024 Oct 06.
Autor:
Mohl BP; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Suedufer 10, 17493 Greifswald, Germany., Diederich S; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Suedufer 10, 17493 Greifswald, Germany., Fischer K; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Suedufer 10, 17493 Greifswald, Germany., Balkema-Buschmann A; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Suedufer 10, 17493 Greifswald, Germany.
Publikováno v:
Viruses [Viruses] 2024 Aug 26; Vol. 16 (9). Date of Electronic Publication: 2024 Aug 26.
Autor:
Barlang LA; Preclinical Safety, AbbVie Deutschland GmbH & Co. KG, Knollstraße, 67061 Ludwigshafen, Germany; Department of Pharmacy, Pharmaceutical Technology and Biopharmacy, Ludwig-Maximilians-University, Butenandtstraße 5‑13, 8133 Munich, Germany; Quantitative, Translational & ADME Sciences, AbbVie Deutschland GmbH & Co. KG, Knollstraße, 67061 Ludwigshafen, Germany. Electronic address: lea-adriana.barlang@abbvie.com., Deimel I; Biologics Drug Product Development Department, AbbVie Deutschland GmbH & Co.KG, Knollstraße, 67061 Ludwigshafen, Germany., Mohl BP; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald- Insel Riems, Germany., Blaurock C; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald- Insel Riems, Germany., Balkema-Buschmann A; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald- Insel Riems, Germany., Weinbender K; Preclinical Safety, AbbVie Deutschland GmbH & Co. KG, Knollstraße, 67061 Ludwigshafen, Germany., Hess B; Quality Control Laboratories, AbbVie Inc. Illinois, USA., Obernolte H; Department of Preclinical Pharmacology and In Vitro Toxicology, Fraunhofer ITEM, Nikolai-Fuchs-Straße 1, 30625 Hannover, Germany., Merkel OM; Department of Pharmacy, Pharmaceutical Technology and Biopharmacy, Ludwig-Maximilians-University, Butenandtstraße 5‑13, 8133 Munich, Germany., Popp A; Preclinical Safety, AbbVie Deutschland GmbH & Co. KG, Knollstraße, 67061 Ludwigshafen, Germany.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 May 01; Vol. 196, pp. 106744. Date of Electronic Publication: 2024 Mar 11.
Autor:
Barlang LA; Preclinical Safety, AbbVie Deutschland GmbH & Co. KG, Knollstraße, 67061 Ludwigshafen, Germany; Department of Pharmacy, Pharmaceutical Technology and Biopharmacy, Ludwig-Maximilians-University, Butenandtstraße 5-13, 8133 Munich, Germany. Electronic address: lea-adriana.keller@gmx.de., Mohl BP; Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald, Insel Riems, Germany., Blaurock C; Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald, Insel Riems, Germany., Harder S; Preclinical Safety, AbbVie Deutschland GmbH & Co. KG, Knollstraße, 67061 Ludwigshafen, Germany., Breithaupt A; Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald, Insel Riems, Germany., Merkel OM; Department of Pharmacy, Pharmaceutical Technology and Biopharmacy, Ludwig-Maximilians-University, Butenandtstraße 5-13, 8133 Munich, Germany., Balkema-Buschmann A; Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald, Insel Riems, Germany., Popp A; Preclinical Safety, AbbVie Deutschland GmbH & Co. KG, Knollstraße, 67061 Ludwigshafen, Germany.
Publikováno v:
Acta histochemica [Acta Histochem] 2023 Oct; Vol. 125 (7), pp. 152077. Date of Electronic Publication: 2023 Jul 29.
Autor:
Blaurock C; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany., Breithaupt A; Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler- Institut, Greifswald-Insel Riems, Germany., Weber S; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany., Wylezich C; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany., Keller M; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany., Mohl BP; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany., Görlich D; Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany., Groschup MH; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany., Sadeghi B; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany., Höper D; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany., Mettenleiter TC; Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany., Balkema-Buschmann A; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany. anne.buschmann@fli.de.
Publikováno v:
Scientific reports [Sci Rep] 2022 Sep 05; Vol. 12 (1), pp. 15069. Date of Electronic Publication: 2022 Sep 05.
Autor:
Rahman SK; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Kerviel A; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Mohl BP; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom., He Y; California NanoSystems Institute, UCLA, Los Angeles, California, USA.; Department of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, California, USA., Zhou ZH; California NanoSystems Institute, UCLA, Los Angeles, California, USA.; Department of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, California, USA., Roy P; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom polly.roy@lshtm.ac.uk.
Publikováno v:
Journal of virology [J Virol] 2020 Sep 29; Vol. 94 (20). Date of Electronic Publication: 2020 Sep 29 (Print Publication: 2020).
Autor:
Mohl BP; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK., Kerviel A; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK., Labadie T; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK., Matsuo E; Microbiology & Immunology, Division of Animal Science, Department of Bioresource Science, Graduate School of Agricultural Science, Kobe University, Kobe City 657-8501, Japan., Roy P; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Publikováno v:
Viruses [Viruses] 2020 Mar 20; Vol. 12 (3). Date of Electronic Publication: 2020 Mar 20.
Autor:
Mohl BP; Department of Pathogen Molecular Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom., Roy P; Department of Pathogen Molecular Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom polly.roy@lshtm.ac.uk.
Publikováno v:
Journal of virology [J Virol] 2019 Sep 30; Vol. 93 (20). Date of Electronic Publication: 2019 Sep 30 (Print Publication: 2019).
Autor:
Mohl BP; From the ‡Department of Pathogen Molecular Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Emmott E; §University of Cambridge, Division of Virology, Department of Pathology, Lab block level 5, Box 237, Addenbrookes Hospital, Cambridge, UK., Roy P; From the ‡Department of Pathogen Molecular Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK; polly.roy@lshtm.ac.uk.
Publikováno v:
Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2017 Nov; Vol. 16 (11), pp. 1990-2005. Date of Electronic Publication: 2017 Aug 29.